that a reluctance to refer patients for unpleasant investigations was a factor, as was the patients' age, particularly if they were over 75 or under 40.5 We found that the mean delay from the onset of symptoms to surgical treatment was 19 weeks for left sided carcinomas and 29 weeks for right sided carcinomas. This is an improvement on the 38 and 31 weeks, respectively, of 1979.4 This may be due to increased recognition of the symptoms of colorectal cancer: 202 patients (70%) with left sided tumours and 77 (87%) with right sided tumours were referred urgently with the correct diagnosis. The apparent improved accuracy in diagnosing right sided malignancies was at the expense of a longer period of symptoms, possibly representing a lack of awareness by the patients of the importance of their general ill health. General practitioners detected 56% of palpable tumours, including 70% of the low rectal carcinomas. Twenty seven (12%) patients with easily palpable tumours were referred for treatment of haemorrhoids without prior rectal examination; they were seen routinely and treatment was delayed.
Although BrMed3' 1990; 301:1534 Methaemoglobinaemia in children treated with prilocainelignocaine cream
The efficacy of prilocaine-lignocaine cream (Emla (eutectic mixture of local anaesthetics), Astra Pharmaceuticals) in reducing the pain of venepuncture and other minor skin procedures in children is well established. It is particularly useful in patients who require repeated skin puncture.' The preparation contains prilocaine 25 g/l and lignocaine 25 g/l in an oily base. Prilocaine is associated with methaemoglobinaemia, two of its metabolites, 4-hydroxy-2-methylaniline and 2-methylaniline (o-toluidine), having been implicated in this condition.
The most alarming report of methaemoglobinaemia after the use of prilocaine-lignocaine cream concerned a 3 month old infant who became cyanosed after 5 g of the cream was applied.2 His methaemoglobin concen- The figure shows the results. The mean methaemoglobin concentration in the control group was 0-46 (SE 0 04)%. The methaemoglobin concentration in the children who received the cream increased to a maximum of 0 85 (0 05)% 10 hours after application (p<0-001). This had fallen to 0 70 (0 05)% by 20 hours and to 0-58 (0 04)% by 24 hours; both these concentrations were'still significantly greater than the control value (p<0-01 and p<0 05 respectively).
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Comment
We found a small but significant increase in methaemoglobin concentration in 1-6 year old children after routine administration of We thank Dr Derek C Heap for help and advice.
